Home / Integrating synthesis, enzyme inhibition and in silico studies: carbamoyl luteolin derivatives targeting Alzheimerâs disease Integrating synthesis, enzyme inhibition and in silico studies: carbamoyl luteolin derivatives targeting Alzheimerâs disease Unknown Integrating synthesis, enzyme inhibition and in silico studies: carbamoyl luteolin derivatives targeting Alzheimerâs disease Unknown ★ 5.0 · 28 reads Sign in to save this Request CodeZLIB.IO18503822 Published2022 Pages1 LanguageUnknown